InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-3.9%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by RUSCKOWSKI STEPHEN H, Chairman & CEO. Director active across 4 companies, notably Quest Diagnostics INC. In total, 17 disclosures have been published. History available since 26 July 2021. The latest transaction was disclosed on 6 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
1,551 sharesCommon StockSEC:0000950170-25-078022:0
7,183 shares0Common Stock, $1 par valueSEC:0001062993-25-008901:0
5,952 shares0Common Stock, $1 par valueSEC:0001062993-24-009783:0
3,049 shares0Common Stock, $1 par valueSEC:0001062993-23-017016:0
3,682 shares0Common StockSEC:0001209191-23-039557:0
2,846 shares0Common StockSEC:0001209191-23-032958:0
82,631 shares@ US$147.8623.0% of flowCommon StockSEC:0001022079-23-000064:0
3,496 shares@ US$140.690.9% of flowCommon StockSEC:0001022079-23-000052:0
5,826 shares@ US$147.861.6% of flowCommon StockSEC:0001022079-23-000037:0
10,037 shares@ US$103.570.0051% mcap2.6% of flowCommon StockSEC:0001022079-22-000104:0
34,898 shares@ US$103.570.018% mcap9.1% of flowCommon StockSEC:0001022079-22-000102:0
70,184 shares@ US$130.090.044% mcap22.6% of flowCommon StockSEC:0001022079-22-000062:0
22,510 shares0Common StockSEC:0001022079-22-000041:0
7,463 shares@ US$130.090.0045% mcap2.3% of flowCommon StockSEC:0001022079-22-000023:0
139,751 shares@ US$95.7950.059% mcap30.4% of flowCommon StockSEC:0001022079-21-000117:0
5,813 shares@ US$95.7950.0025% mcap1.3% of flowCommon StockSEC:0001022079-21-000115:0
7,239 sharesDeferred Stock UnitsSEC:0001127602-16-037214:0
17 of 17 declarations
About RUSCKOWSKI STEPHEN H
Stephen H. Rusckowski is the Chairman, CEO and President of Quest Diagnostics Inc. He leads the company by implementing strategies aimed at strengthening its position in the diagnostics market. His leadership is essential for the growth of Quest Diagnostics.
